Key takeaways
- The decision to sell is not just about current value; it is about the present value of remaining in the business versus the risk-adjusted value of the alternative.
- Valuation inflection points, the moments when a business crosses a threshold that significantly expands the buyer universe or the applicable multiple, are among the most powerful reasons to delay a sale.
- Selling below $3M EBITDA in many sectors means accepting a compressed multiple that may be 1.5x to 2.5x lower than the multiple available just 18 to 24 months later with continued growth.
- Alternatives to a full sale, including minority recapitalizations, dividend recaps, and selective growth investments, can provide near-term liquidity without requiring a full exit at a suboptimal moment.
Most founder exit planning focuses on how to sell: how to prepare the business, how to run the process, and how to negotiate the deal. The prior question, whether this is the right moment to sell at all, receives far less analytical attention and is often decided on the basis of personal readiness, advisor recommendations, or market noise rather than rigorous valuation and alternatives analysis.
The most expensive exit planning mistake is not a bad process or a weak negotiation. It is selling at the wrong moment. A founder who sells a $1.8M EBITDA business at 4x on a positive growth trajectory may be leaving $4M to $8M on the table compared to selling the same business at $3.5M EBITDA two years later at a 5x multiple. The compounding of EBITDA growth and multiple expansion is the most powerful valuation lever available to a founder, and selling before that inflection is a form of permanent value destruction.
EBITDA multiple compression below $2M EBITDA averages 1.8x lower than comparable businesses above $5M EBITDA, with the largest expansion occurring at the $2M-$4M EBITDA threshold where institutional PE interest significantly broadens (GF Data 2024).
Businesses growing EBITDA at 15% or more annually that sold in year one of a growth acceleration received median proceeds 38% lower than comparable businesses that waited 24 months and sold at the higher EBITDA with the associated multiple expansion.
Valuation inflection points: the most powerful reason to wait
Valuation multiples in the lower middle market are not linear with EBITDA. They are tier-driven, with significant multiple expansion occurring at specific EBITDA thresholds that reflect changes in buyer universe, financing availability, and institutional interest.
A business generating $1.8M EBITDA at 4x produces an enterprise value of $7.2M. The same business at $3.2M EBITDA (18 months of 20% growth) at 5.5x produces $17.6M. The difference is $10.4M in enterprise value, driven partly by EBITDA growth and partly by multiple expansion as the business crosses into a buyer tier with deeper institutional demand. Founders who are within 12 to 24 months of a valuation inflection point often have the most to gain from waiting.
Evaluating whether you are selling too early
The right analytical framework for the timing decision is a comparison of two scenarios: selling now at the current value, versus remaining independent for 18 to 36 months and selling then. The comparison requires modeling: the expected EBITDA growth rate over the waiting period; the multiple expansion likely associated with crossing the next valuation tier; the personal and financial cost of remaining in the business (including opportunity cost, compensation, and lifestyle factors); and the risk that performance deteriorates or market conditions worsen during the waiting period.
Framework for Evaluating Exit Timing
Step 1: Model the current enterprise value
Apply current EBITDA to the applicable multiple range for your business size, sector, and growth profile. This is your baseline.
Step 2: Model the 18-24 month scenario
Project forward EBITDA at a realistic growth rate. Apply the multiple range applicable at the projected EBITDA level, including any multiple expansion from crossing a tier threshold.
Step 3: Calculate the stay-in cost
What does remaining in the business cost personally and financially? Salary continuation, opportunity cost, management stress, and personal lifestyle factors all have economic value.
Step 4: Apply a risk discount
The 18-24 month forward scenario carries execution risk. Apply a realistic discount for the probability that growth does not materialize as projected or that market conditions deteriorate.
Step 5: Compare risk-adjusted outcomes
If the risk-adjusted forward scenario produces 30% or more in additional proceeds, the quantitative case for waiting is strong. If the premium is under 20%, personal and lifestyle factors should drive the decision.
A founder of a $9M revenue professional services business was generating $1.9M EBITDA and had received an informal indication at 4.2x ($8M enterprise value). An operating advisor modeled the forward scenario: at 18% annual EBITDA growth (the trailing 2-year average), EBITDA would reach $2.6M in 18 months. At that size, the applicable multiple was 5.0x to 5.5x, producing an enterprise value of $13M to $14.3M. Risk-discounting the forward scenario at 30% (reflecting execution and market risk) produced a risk-adjusted expected value of $9.1M to $10.0M, compared to $8M today. The quantitative case was marginal. The founder chose to wait, reached $2.7M EBITDA 20 months later, and sold at 5.3x for $14.3M, a $6.3M improvement over the original indication.
Alternatives to a full sale
Founders who determine they are selling too early but need near-term liquidity have options short of a full exit. A minority recapitalization sells 20 to 40 percent of equity to a PE partner, providing immediate liquidity while retaining control and the majority of the second-bite upside. A dividend recapitalization has the business borrow against its own cash flow to distribute capital to the owner, providing personal liquidity without any equity dilution but adding leverage to the capital structure.
For founders who need personal liquidity but not a full exit, these alternatives are worth explicit analysis before committing to a sale process. The cost of a minority recap or a dividend recap is real (equity dilution or debt service), but it may be substantially less than the enterprise value left on the table by selling at the wrong moment.
Scroll to see more →
When it actually is the right time to sell
The case for waiting is not always the right answer. There are conditions under which selling at the current moment is the highest-value decision regardless of forward growth potential. The business has reached a valuation plateau and the next inflection point would require capital, risk, or management commitment that the founder is not willing to make. Market conditions are at a cyclical peak and the current multiple environment is unlikely to be replicated in 18 to 24 months. The founder's personal situation, health, family priorities, or opportunity cost, makes continued operating involvement genuinely costly. Or the business faces specific risk factors, customer concentration, competitive threat, or regulatory change, that create asymmetric downside in a waiting scenario.
The right exit timing decision is one that integrates the quantitative analysis with an honest assessment of personal readiness, risk tolerance, and the specific conditions facing the business. Founders who make this decision through a rigorous analytical framework, rather than advisor urgency or market noise, consistently achieve better outcomes.
Frequently asked questions
How do I know if I'm selling my business at the wrong time?
The primary signal is that you are within 18 to 24 months of a EBITDA threshold that would significantly expand your buyer universe and the applicable multiple. The secondary signal is a growth rate that implies material EBITDA increase in that window. If both are true, the quantitative case for waiting is typically strong unless market conditions or personal factors justify the current timeline.
What is a valuation inflection point?
A valuation inflection point is a level of EBITDA or enterprise value at which the applicable multiple range increases materially because the buyer universe expands significantly. In the lower middle market, the most significant inflection points occur at approximately $2M, $4M, and $7M EBITDA. Selling just below an inflection point often leaves more value on the table than any negotiation tactic could recover.
What are the alternatives to selling my business if I need liquidity?
The two primary alternatives are a minority recapitalization (selling 20-40% of equity to a PE partner for immediate liquidity while retaining control and upside) and a dividend recapitalization (having the business borrow against its cash flow to distribute capital to the owner). Both provide liquidity without requiring a full exit. Which is appropriate depends on the business's leverage capacity and the founder's equity dilution tolerance.
Work with Glacier Lake Partners
Discuss Your Exit Timing and Options
The most important exit planning conversation is often whether this is the right moment to sell, not just how to execute a sale.
Start a Conversation →Research sources
Explore adjacent topics
